To me, this sounds like plenty of upside - but it will be a v slow train.
(1) Because the first mill was such a poorly executed concept, PNR is capital deprived until this operation is at 120koz with a higher grade.
(2) The Butterfly NW structure target on page 20 - even this 'easy' exploration target now looks high capital & risk exploration to me as a S/H (!!!). And I am a holder from its early days, with some averaging down.
(3) This goldfield still needs another investment for an additional annual 130koz production (250koz at least) to handle open pits.
All I see is an easy $400 m takeover, with the new owners still needing even more capital for expanded mill. But existing shareholders will be easily enticed to exit at 8c anytime this year.
- Forums
- ASX - By Stock
- PNR
- Ann: Investor Update Presentation
Ann: Investor Update Presentation, page-3
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
Add PNR (ASX) to my watchlist
(20min delay)
|
|||||
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $806.7M |
Open | High | Low | Value | Volume |
12.5¢ | 12.5¢ | 12.0¢ | $498.7K | 4.028M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1446042 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 1533711 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 1446042 | 0.120 |
13 | 840755 | 0.115 |
18 | 1779688 | 0.110 |
17 | 1647224 | 0.105 |
21 | 1226748 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 1533711 | 14 |
0.130 | 7028532 | 33 |
0.135 | 2915765 | 13 |
0.140 | 1132119 | 17 |
0.145 | 1592119 | 8 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
PNR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online